Implementation of noninvasive neurally adjusted ventilatory assist in pediatric acute respiratory failure: a controlled before-after quality improvement study

Table 1 Baseline characteristics of patients

	NIV-PS n = 34	NIV-NAVA n = 30	P value
Patients characteristics
Male, n (%)	15 (45)	15 (30)	0.768
Age, mos	12, 6–21	11, 5–22	0.181
Weight, Kg	8, 6–12	8, 7–11	0.784
PIM2	1, 1–2	1, 1–1.5	0.569
paO₂:FiO₂	140, 116–180	143, 119–171	0.805
paCO₂, mmHg	46, 40–52	45, 43–54	0.724
RR, breaths min⁻¹	60, 55–66	60, 33–70	0.076
HR, beats min⁻¹	134, 121–143	132, 120–133	0.079
MAP, mmHg	55, 50–56	55, 55–67	0.745
Causes of AHRF
Viral infection, n (%)	15 (50)	17 (56)	0.694
Bacterial infection, n (%)	5 (17)	3 (10)	0.694
Comorbidities
Mechanical ventilation at birth, n (%)	5 (17)	3 (10)	1
Epilepsy, n (%)	2 (7)	2 (7)	1
Uncorrected congenital heart disease, n (%)	1 (4)	2 (7)	1

NIV-PS noninvasive pressure support, NIV-NAVA noninvasive neurally adjusted ventilatory assist, PIM2 Pediatric Index Mortality 2, paO₂:FiO₂ arterial oxygen tension to inspired oxygen fraction ratio, paCO₂ arterial carbon dioxide tension, RR respiratory rate, HR heart rate, MAP mean arterial pressure, AHRF acute hypoxemic respiratory failure. Data are expressed as median [1–3 IQR]

ISSN: 2731-3786